Received: 14 October 2019
Accepted: 27 January 2020
First Online: 15 April 2020
Ethics approval and consent to participate
: It is approved by National Liver Institute IRB 0088/2014. Informed written consent was signed by all patients.
: Not applicable
: Imam Waked is an investigator and/or speaker for Abbvie, Gilead Sciences, Janssen, Marcyrl, Onxio, and Pharco. The rest of the authors declare that they have no competing interests.